Breast cancers are traditionally categorized into four molecular subtypes based on the IHC expression of classic hormone and growth factor receptors including the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), as well as a proliferation marker Ki-67 protein expression (2). This evidence concerns the gene PGR and breast carcinoma.